IQGAP3 and urinary bladder cancer: Furthermore, IQGAP3 can distinguish myoinvasive bladder cancer (MIBC) from non-myoinvasive bladder cancer (NMIBC), achieving sensitivity and specificity maxima of 93.8% and 80.0% for MIBC and 89.5% and 90.7% for NMIBC with PicoGreen-corrected AUCs of 0.944 and 0.87, respectively (Kim et al., 2018).